IBI – International Biopharmaceutical Industry

Current Edition

Volume 6 Issue 3

Current Features

Current Features

Rapid Evolution of the Biotech Industry: 2023 and Beyond

The Fast Pace of Biotech The biopharmaceutical industry has embraced the adage of “Don’t be afraid of change, welcome it.” In doing so, the industry has fuelled a st...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

A Summary of the Pharmaceutical Development Process, the Changes and Challenges and Future Opportunities

In this white paper, Broughton summarises the ‘historical’ development plan for pharmaceuticals, the changes that have occurred with regards to differential developme...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Developing Robust Analytical Methods for Early-Stage Biologics

Biologics are a broad class of therapeutic agents, encompassing vaccines, monoclonal antibodies, therapeutic proteins, nucleic acid-based therapies, blood components,...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

How to Develop a Successful in vitro Screening Strategy

Developing a drug can take years and comes with significant costs. During the early phases of this journey, it is vital to have a robust process in place to allow rap...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Accelerating Biologics Manufacturing: Strategies for Efficient Production Timelines

Optimised development and manufacturing processes that accelerate biologic production timelines while keeping costs down are critical to meeting the market demand. St...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

How Can the Pharmaceutical Industry Overcome Barriers to Reducing its Carbon Footprint?

Åsa Bergström, Director of Sustainability, Recipharm explores how pharmaceutical companies can address challenges to making a meaningful contribution to globa...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Advertisement

Current Edition

Volume 6 Issue 3

Current Features

Rapid Evolution of the Biotech Industry: 2023 and Beyond

The Fast Pace of Biotech The biopharmaceutical industry has embraced the adage of “Don’t be afraid of change, welcome it.” In doing so, the industry has fuelled a st...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

A Summary of the Pharmaceutical Development Process, the Changes and Challenges and Future Opportunities

In this white paper, Broughton summarises the ‘historical’ development plan for pharmaceuticals, the changes that have occurred with regards to differential developme...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Developing Robust Analytical Methods for Early-Stage Biologics

Biologics are a broad class of therapeutic agents, encompassing vaccines, monoclonal antibodies, therapeutic proteins, nucleic acid-based therapies, blood components,...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

How to Develop a Successful in vitro Screening Strategy

Developing a drug can take years and comes with significant costs. During the early phases of this journey, it is vital to have a robust process in place to allow rap...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Accelerating Biologics Manufacturing: Strategies for Efficient Production Timelines

Optimised development and manufacturing processes that accelerate biologic production timelines while keeping costs down are critical to meeting the market demand. St...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

How Can the Pharmaceutical Industry Overcome Barriers to Reducing its Carbon Footprint?

Åsa Bergström, Director of Sustainability, Recipharm explores how pharmaceutical companies can address challenges to making a meaningful contribution to globa...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Innovative Laboratory Testing Methods for Clinical Monitoring of Cell Therapies Using Flow Cytometry ddPCR and qPCR Assays

Gene-modified cell therapy for the treatment of cancer and other diseases is a rapidly growing area of clinical research. The therapeutic use of engineered cells has ...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Current Features

Using a LIMS to Improve Bottom Line Profitability

The Model T Ford is still discussed in business schools today because of how Henry Ford relentlessly drove quality and innovation. When first introduced in 1908 the M...

14 September 2023 Current Features | Volume 6 Issue 3

Continue Reading →

Company Profiles

Company Profile

éclateral

éclateral is a diagnostic/tech start-up creating the next generation of lateral flow tests. Our team comprises scientists and engineers, all united by our shared pa...

30 October 2023 Company Profile | E-M

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte